Boston Financial Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,599
Closed -$253K 309
2023
Q1
$253K Hold
1,599
0.01% 287
2022
Q4
$224K Buy
1,599
+20
+1% +$2.84K 0.01% 301
2022
Q3
$203K Sell
1,579
-33
-2% -$4.76K 0.01% 294
2022
Q2
$227K Hold
1,612
0.01% 272
2022
Q1
$224K Sell
1,612
-64
-4% -$9.81K 0.01% 272
2021
Q4
$292K Hold
1,676
0.01% 232
2021
Q3
$278K Buy
+1,676
New +$289K 0.01% 228
2020
Q3
Sell
-822
Closed -$180K 245
2020
Q2
$180K Sell
822
-490
-37% -$97.9K 0.01% 241
2020
Q1
$227K Buy
+1,312
New +$217K 0.01% 212
2014
Q1
Sell
-7,175
Closed -$666K 202
2013
Q4
$666K Sell
7,175
-875
-11% -$78.8K 0.09% 151
2013
Q3
$658K Sell
8,050
-25
-0.3% -$2.11K 0.1% 148
2013
Q2
$671K Buy
+8,075
New +$695K 0.1% 148

Other funds holding CLX

Boston Financial Management's CLX Position: Q2 2023 in Review

Boston Financial Management sold out of Clorox (CLX) in Q2 2023, closing a stake of 1,599 shares — an estimated $253K sold.

Boston Financial Management first reported a position in CLX in Q2 2013 and held it in 12 quarters. The position peaked at $671K in Q2 2013. 1,143 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

  • Boston Financial Management reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
  • Boston Financial Management sold 1,599 Clorox shares in Q2 2023, an estimated $253K.
  • Boston Financial Management first reported a position in Clorox in Q2 2013 and held it in 12 quarters.
  • Boston Financial Management's Clorox position peaked at $671K in Q2 2013.
  • 1,143 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on Boston Financial Management's 13F filing for Q2 2023, filed 7 Aug 2023.